海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2015年
15期
2234-2236
,共3页
罗恒%侯飞%樊宁%成洪波%赖铭莹
囉恆%侯飛%樊寧%成洪波%賴銘瑩
라항%후비%번저%성홍파%뢰명형
急性闭角型青光眼%超声乳化白内障摘除%疗效%风险
急性閉角型青光眼%超聲乳化白內障摘除%療效%風險
급성폐각형청광안%초성유화백내장적제%료효%풍험
Acute angle closure glaucoma%Phacoemulsification%Eflect%Risk
目的:评估急性闭角型青光眼高眼压下行超声乳化白内障摘除联合人工晶体植入手术的疗效和风险。方法回顾性分析2013年5月至2014年9月在我科高眼压下急诊行超声乳化白内障摘除联合人工晶体植入手术治疗的急性闭角型青光眼患者17例17眼,术后随访1个月,观察手术前后视力、眼压、角膜内皮细胞计数及术中并发症。结果术前平均眼压(43.82±6.50) mmHg,术后1 d平均眼压(20.12±10.09) mmHg,术后1个月平均眼压(14.21±5.39) mmHg,15眼眼压≤21 mmHg,2眼联合1~2种抗青光眼药物眼压≤21 mmHg,术后1个月平均眼压与术前平均眼压比较,差异有显著统计学意义(P<0.01)。术后1个月15眼视力较术前提高。全部病例术后未发生角膜内皮失代偿,眼压控制后角膜水肿均获得改善。术中3眼晶体不全脱位,2眼晶体后囊破裂,1眼局限性脉络膜出血。结论对于药物治疗眼压不能控制、病情逐渐加重的急性闭角型青光眼患者,急诊行超声乳化白内障摘除联合人工晶体植入手术治疗成功率较高,治疗安全有效,术后眼压控制良好,术后视力明显提高。
目的:評估急性閉角型青光眼高眼壓下行超聲乳化白內障摘除聯閤人工晶體植入手術的療效和風險。方法迴顧性分析2013年5月至2014年9月在我科高眼壓下急診行超聲乳化白內障摘除聯閤人工晶體植入手術治療的急性閉角型青光眼患者17例17眼,術後隨訪1箇月,觀察手術前後視力、眼壓、角膜內皮細胞計數及術中併髮癥。結果術前平均眼壓(43.82±6.50) mmHg,術後1 d平均眼壓(20.12±10.09) mmHg,術後1箇月平均眼壓(14.21±5.39) mmHg,15眼眼壓≤21 mmHg,2眼聯閤1~2種抗青光眼藥物眼壓≤21 mmHg,術後1箇月平均眼壓與術前平均眼壓比較,差異有顯著統計學意義(P<0.01)。術後1箇月15眼視力較術前提高。全部病例術後未髮生角膜內皮失代償,眼壓控製後角膜水腫均穫得改善。術中3眼晶體不全脫位,2眼晶體後囊破裂,1眼跼限性脈絡膜齣血。結論對于藥物治療眼壓不能控製、病情逐漸加重的急性閉角型青光眼患者,急診行超聲乳化白內障摘除聯閤人工晶體植入手術治療成功率較高,治療安全有效,術後眼壓控製良好,術後視力明顯提高。
목적:평고급성폐각형청광안고안압하행초성유화백내장적제연합인공정체식입수술적료효화풍험。방법회고성분석2013년5월지2014년9월재아과고안압하급진행초성유화백내장적제연합인공정체식입수술치료적급성폐각형청광안환자17례17안,술후수방1개월,관찰수술전후시력、안압、각막내피세포계수급술중병발증。결과술전평균안압(43.82±6.50) mmHg,술후1 d평균안압(20.12±10.09) mmHg,술후1개월평균안압(14.21±5.39) mmHg,15안안압≤21 mmHg,2안연합1~2충항청광안약물안압≤21 mmHg,술후1개월평균안압여술전평균안압비교,차이유현저통계학의의(P<0.01)。술후1개월15안시력교술전제고。전부병례술후미발생각막내피실대상,안압공제후각막수종균획득개선。술중3안정체불전탈위,2안정체후낭파렬,1안국한성맥락막출혈。결론대우약물치료안압불능공제、병정축점가중적급성폐각형청광안환자,급진행초성유화백내장적제연합인공정체식입수술치료성공솔교고,치료안전유효,술후안압공제량호,술후시력명현제고。
Objective To evaluate the effect and risk of phacoemulsification combined intraocular lens im-plantation under high intraocular pressure (IOP) in treating acute angle closure glaucoma (AACG). Methods Seven-teen patients (17 eyes) of AACG who received the treatment (phacoemulsification combined intraocular lens implanta-tion under high IOP) in our department during May 2013 to September 2014 were retrospectively analyzed. All pa-tients were followed up for one month, with visual acuities (VA), IOP, the number of corneal endothelial cells and com-plications observed. Results The average IOP was (43.82 ± 6.50) mmHg before the surgery, (20.12 ± 10.09) mmHg one day after the surgery, and (14.21 ± 5.39) mmHg one month after the surgery. At the time point of one month after the surgery, the IOPs of 15 eyes without any drugs and 2 eyes treated with 1~2 kinds of anti-glaucoma drugs were all normal (≤21 mmHg). The difference was statistically significant (P<0.01). One month after the surgery, the VAs of 15 eyes were all improved, with no postoperative corneal endothelial decompensation found, and corneal edema were improved after intraocular pressure control. Abnormal complications included lens subluxation of 3 eyes, posterior capsule rupture of 2 eyes, and limited choroid hemorrhage of 1 eye. Conclusion Phacoemulsification is a relatively safe and effective treatment for those AACG patients who found drug therapy ineffective. The IOP and VA can be well controlled and improved significantly after the surgery.